Albarah El-khani

Albarah El-khani is the Chief Operating Officer of Integrated Health Solutions at M42, where he leads programs that bring together multiomics, advanced diagnostics, preventive screening, environmental health, biobanking, and precision clinical research to transform population health. With a background in clinical medical microbiology, he combines scientific expertise with strategic delivery on a scale.

Albarah has played a pivotal role in building national platforms that shift healthcare upstream, enabling earlier detection, proactive prevention, more accurate diagnosis, and personalized intervention. He has played a central role in advancing the Emirati Genome Program, one of the most ambitious population genomics efforts in the world, and continues to shape initiatives that drive meaningful, system-wide impact.

Before that, El-khani served as the Senior Vice President of Operations at M42, where his leadership was instrumental in driving the organization's strategic direction towards precision and personalized medicine. With a rich background spanning over two decades in the healthcare industry, Albarah's journey began with a solid academic foundation in Clinical Medical Microbiology, obtained from Westminster University in London. His career has been marked by significant contributions and leadership roles across the UK and GCC regions, demonstrating a profound commitment to healthcare excellence and innovation.

Notably, Albarah served as the Chief Operating Officer at the National Reference Laboratory in the UAE, where his strategic initiatives significantly contributed to operational efficiencies and elevated standards in healthcare practices. This role underscored his ability to navigate complex healthcare landscapes and implement transformative strategies that enhance patient care and organizational performance.

Currently, at M42, Albarah leverages his extensive experience and operational acumen to lead the organization's efforts in adopting cutting-edge approaches to healthcare. His work is focused on the integration of precision and personalized medicine into mainstream healthcare delivery, aiming to set new benchmarks for quality and efficiency.